# Nuclide record y-90 (isotope). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/isotopes/y-90/>
  a schema:ChemicalSubstance ;
  nuclide:kind "isotope" ;
  schema:identifier "y-90" ;
  schema:name "Yttrium-90"@en ;
  schema:alternateName "90Y"@en, "Y-90"@en ;
  schema:description "A radioactive metal that fires high-energy particles a short distance into surrounding tissue. Millions of microscopic beads carrying it are injected into the artery feeding a liver tumour, where they lodge and irradiate the tumour from inside."@en ;
  schema:url <https://nuclide.cc/isotopes/y-90/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/cdrh_docs/pdf20/P200029C.pdf>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC5514171/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC7732571/> ;
  nuclide:status "approved" ;
  nuclide:tag "therapy", "beta emitter", "radioembolisation" ;
  nuclide:related <https://nuclide.cc/technologies/radioembolisation-tare/>, <https://nuclide.cc/terms/tare/>, <https://nuclide.cc/indications/hcc/>, <https://nuclide.cc/indications/hcc-intermediate/>, <https://nuclide.cc/drugs/ibritumomab-tiuxetan/>, <https://nuclide.cc/companies/sirtex/>, <https://nuclide.cc/companies/boston-scientific/> .
